Search
Twitter-square Facebook-square Linkedin Youtube

Rights Trading Commences

Rights Trading Commences

Imagion Biosystems Limited (ASX:IBX) is pleased to confirm that the rights the subject of the Company’s Renounceable Rights Issue announced on Wednesday, 25 March 2020, have commenced trading under the ASX code IBXRA on a deferred settlement basis.

Under the Rights Issue timetable the rights trading will end on Thursday, 14 April 2020. The Prospectus and Entitlement and Acceptance Form is expected to be sent to Eligible Shareholders on Wednesday, 1 April 2020.

View the Rights Trading announcement.

Related Articles

Successful Placement of A$3M

October 10, 2024

Imagion Biosystems (ASX: IBX) (Company), is pleased to announce the Company has received $3 million of firm commitments through a highly successful capital raising. The

Read More

Transforming medical imaging for early disease detection

We’re on a mission to make cancer more detectable.

Get in touch

About Imagion Biosystems

Imagion Biosystems (IBX) is an innovative medical imaging company that uses bio-safe magnetic nanoparticles to detect cancer and other diseases.

Contact us

Join our email list

Stay informed about our latest news and developments.

© Imagion Biosystems, Ltd. All Rights Reserved | Privacy Policy | Terms & Conditions | Careers | Corporate Governance

Twitter-square Facebook-square Linkedin Youtube